CASADEI, CHIARA
CASADEI, CHIARA
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy
2021 Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravaglia G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U.
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
2021 Conteduca V.; Wetterskog D.; Castro E.; Scarpi E.; Romero-Laorden N.; Gurioli G.; Jayaram A.; Lolli C.; Schepisi G.; Wingate A.; Casadei C.; Lozano R.; Brighi N.; Aragon I.M.; Marin-Aguilera M.; Gonzalez-Billalabeitia E.; Mellado B.; Olmos D.; Attard G.; De Giorgi U.
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
2021 Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C.; De Giorgi U.
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
2020 Schepisi G.; Conteduca V.; Casadei C.; Gurioli G.; Rossi L.; Galla V.; Cursano M.C.; Brighi N.; Lolli C.; Menna C.; Farolfi A.; Burgio S.L.; Altavilla A.; Martinelli G.; De Giorgi U.
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience
2019 Ricci, C.; Campana, D.; Casadei, C.; Ingaldi, C.; Ambrosini, V.; Pagano, N.; Santini, D.; Mosconi, C.; Brighi, N.; Alberici, L.; Minni, F.; Casadei, R.
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors
2019 Schepisi G.; Brighi N.; Cursano M.C.; Gurioli G.; Ravaglia G.; Altavilla A.; Burgio S.L.; Testoni S.; Menna C.; Farolfi A.; Casadei C.; Tonini G.; Santini D.; De Giorgi U.
Plasma androgen receptor in prostate cancer
2019 Conteduca V.; Gurioli G.; Brighi N.; Lolli C.; Schepisi G.; Casadei C.; Burgio S.L.; Gargiulo S.; Ravaglia G.; Rossi L.; Altavilla A.; Farolfi A.; Menna C.; Colangione S.P.; Pulvirenti M.; Romeo A.; De Giorgi U.
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment
2019 Nicole Brighi, Alberto Farolfi, Vincenza Conteduca, Giorgia Gurioli, Stefania Gargiulo, Valentina Gallà, Giuseppe Schepisi, Cristian Lolli, Chiara Casadei, Ugo De Giorgi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy | Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravagli...a G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-00840-v2.pdf |
| Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study | Conteduca V.; Wetterskog D.; Castro E.; Scarpi E.; Romero-Laorden N.; Gurioli G.; Jayaram A.; Lol...li C.; Schepisi G.; Wingate A.; Casadei C.; Lozano R.; Brighi N.; Aragon I.M.; Marin-Aguilera M.; Gonzalez-Billalabeitia E.; Mellado B.; Olmos D.; Attard G.; De Giorgi U. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives | Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C....; De Giorgi U. | 2021-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors | Schepisi G.; Conteduca V.; Casadei C.; Gurioli G.; Rossi L.; Galla V.; Cursano M.C.; Brighi N.; L...olli C.; Menna C.; Farolfi A.; Burgio S.L.; Altavilla A.; Martinelli G.; De Giorgi U. | 2020-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-10-565857.pdf |
| A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience | Ricci, C.; Campana, D.; Casadei, C.; Ingaldi, C.; Ambrosini, V.; Pagano, N.; Santini, D.; Mosconi..., C.; Brighi, N.; Alberici, L.; Minni, F.; Casadei, R. | 2019-01-01 | ENDOCRINE | - | 1.01 Articolo in rivista | - |
| Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors | Schepisi G.; Brighi N.; Cursano M.C.; Gurioli G.; Ravaglia G.; Altavilla A.; Burgio S.L.; Testoni... S.; Menna C.; Farolfi A.; Casadei C.; Tonini G.; Santini D.; De Giorgi U. | 2019-01-01 | JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | 7317964.pdf |
| Plasma androgen receptor in prostate cancer | Conteduca V.; Gurioli G.; Brighi N.; Lolli C.; Schepisi G.; Casadei C.; Burgio S.L.; Gargiulo S.;... Ravaglia G.; Rossi L.; Altavilla A.; Farolfi A.; Menna C.; Colangione S.P.; Pulvirenti M.; Romeo A.; De Giorgi U. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-01719.pdf |
| The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment | Nicole Brighi, Alberto Farolfi, Vincenza Conteduca, Giorgia Gurioli, Stefania Gargiulo, Valentina... Gallà, Giuseppe Schepisi, Cristian Lolli, Chiara Casadei, Ugo De Giorgi | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-01935.pdf |